Kling Douglas F
SEC insider (Form 3/4/5 filer). CIK 0001699022. Chief Operating Officer at NewAmsterdam Pharma Co N.V. (NAMS). 37 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2025. Located in NAARDEN, P7.
Companies Kling Douglas F has filed insider reports for
- NewAmsterdam Pharma Co N.V. (NAMS): Officer, Chief Operating Officer
Kling Douglas F
CIK: 0001699022
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NewAmsterdam Pharma Co N.V.
Discretionary Trading P&L
Holdings
Transaction History (37 total)
- Jul 16, 2025NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect51K shares at avg. $21.10$1.1M - Jul 16, 2025NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect51K shares at avg. $10.90$556K - Jul 15, 2025NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect47.6K shares at avg. $10.90$519K - Jul 15, 2025NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect44K shares at avg. $21.38$941K - Jul 15, 2025NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect3.5K shares at avg. $22.12$78K - Jun 16, 2025NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect21.9K shares at avg. $10.90$239K - Jun 16, 2025NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect81.9K shares at avg. $19.19$1.6M - Jun 16, 2025NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect18.1K shares at avg. $19.75$358K - Jun 16, 2025NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect78.1K shares at avg. $10.00$781K - May 15, 2025NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect100K shares at avg. $10.00$1.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 51,043 | $21.10 | $1,077,007 | Direct |
| Jul 16, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 51,043 | $10.90 | $556,369 | Direct |
| Jul 15, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 47,569 | $10.90 | $518,502 | Direct |
| Jul 15, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 44,025 | $21.38 | $941,255 | Direct |
| Jul 15, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 3,544 | $22.12 | $78,393 | Direct |
| Jun 16, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 21,899 | $10.90 | $238,699 | Direct |
| Jun 16, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 81,891 | $19.19 | $1,571,488 | Direct |
| Jun 16, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 18,109 | $19.75 | $357,653 | Direct |
| Jun 16, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 78,101 | $10.00 | $781,010 | Direct |
| May 15, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 100,000 | $10.00 | $1,000,000 | Direct |
1-10 of 37 transactions